VIRUSINHIBITORER

Pyrrolo[2,3-c]pyridine or pyrrolo[3,2-c]pyridine compounds having the general formula (A), wherein the dashed lines, X, Y and R1 through R5 are as defined in the specification. The compounds are useful in the prophylaxis or treatment of viral infections.

Saved in:
Bibliographic Details
Main Authors BONDY, STEVEN, S, PUERSTINGER, GERHARD, OARE, DAVID, A
Format Patent
LanguageDanish
Published 07.12.2015
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract Pyrrolo[2,3-c]pyridine or pyrrolo[3,2-c]pyridine compounds having the general formula (A), wherein the dashed lines, X, Y and R1 through R5 are as defined in the specification. The compounds are useful in the prophylaxis or treatment of viral infections.
AbstractList Pyrrolo[2,3-c]pyridine or pyrrolo[3,2-c]pyridine compounds having the general formula (A), wherein the dashed lines, X, Y and R1 through R5 are as defined in the specification. The compounds are useful in the prophylaxis or treatment of viral infections.
Author PUERSTINGER, GERHARD
BONDY, STEVEN, S
OARE, DAVID, A
Author_xml – fullname: BONDY, STEVEN, S
– fullname: PUERSTINGER, GERHARD
– fullname: OARE, DAVID, A
BookMark eNrjYmDJy89L5WQQCPMMCg329PPwdPIM8Q9yDeJhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfEu3kYGlibmBkYhIcbGxKgBAOkCH-0
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID DK2094702TT3
GroupedDBID EVB
ID FETCH-epo_espacenet_DK2094702TT33
IEDL.DBID EVB
IngestDate Fri Jul 19 15:59:32 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Danish
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_DK2094702TT33
Notes Application Number: DK20070874175T
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20151207&DB=EPODOC&CC=DK&NR=2094702T3
ParticipantIDs epo_espacenet_DK2094702TT3
PublicationCentury 2000
PublicationDate 20151207
PublicationDateYYYYMMDD 2015-12-07
PublicationDate_xml – month: 12
  year: 2015
  text: 20151207
  day: 07
PublicationDecade 2010
PublicationYear 2015
RelatedCompanies K.U. LEUVEN RESEARCH AND DEVELOPMENT
GILEAD SCIENCES, INC
PUERSTINGER, GERHARD
RelatedCompanies_xml – name: K.U. LEUVEN RESEARCH AND DEVELOPMENT
– name: PUERSTINGER, GERHARD
– name: GILEAD SCIENCES, INC
Score 3.0143936
Snippet Pyrrolo[2,3-c]pyridine or pyrrolo[3,2-c]pyridine compounds having the general formula (A), wherein the dashed lines, X, Y and R1 through R5 are as defined in...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title VIRUSINHIBITORER
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20151207&DB=EPODOC&locale=&CC=DK&NR=2094702T3
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSbIAnQtnaqlrapqUqmuSaGygm2RoZqBrlGqUkpZikWaZkgjqKPr6mXmEmnhFmEYwMWTC9sKAzwktBx-OCMxRycD8XgIurwsQg1gu4LWVxfpJmUChfHu3EFsXNWjvGFR9GZiruTjZugb4u_g7qzk727p4q_kFAeUsTcwNjEKMmRlYga1oc1BmcA1zAm1KKUCuUdwEGdgCgIbllQgxMKUkCjNwOsMuXhNm4PCFzncDmdCsVyzCIBDmGQS6I8PD08kzxD_INUiUQdHNNcTZQxdodDzcG_Eu3jBHhBgbizGwALv3qRIMCmapxmmJyaCDzdOMTUzSki1STVKMDJINjJJSDC3TEpMkGaRwmyOFT1KagQsUJODFF-YyDCwlRaWpssAqtCRJDux5AMmNc2k
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFOeTOhWd3yB9K3ZNPx-K0C9au7ajxLG30TQt7EWHq_jvm4RWfdG3kIMjOfjlcsnd7wAeiMV54XRb1nVSy1qJFJlMDUVWa5U21GpsWvJAMc2M6EV7XurLAaz7WhjBE_opyBEZoiqG91ac15ufRyxf5FZuH8maTb09hdjxpS465u5LMSXfdYJ57uee5HmOn0hZwWS2ZioqRjuwy27YJgdDsHB5Ucrmt0cJj2BvzpS9tscwoOUYRl7feG0M-2n3382GHfS2J3C4iAveIyOK3RjnRVCcwn0YYC-SmerV9zZWftIvAiN0BkMW3tfncGfUqCkrTmzeIE1rKqvWqKpUikro1G5KcgGTv_VM_hPewijC6Ww1i7PkEg64eUQihnkFw_b9o75m7rQlN8IQX10udlw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=VIRUSINHIBITORER&rft.inventor=BONDY%2C+STEVEN%2C+S&rft.inventor=PUERSTINGER%2C+GERHARD&rft.inventor=OARE%2C+DAVID%2C+A&rft.date=2015-12-07&rft.externalDBID=T3&rft.externalDocID=DK2094702TT3